Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-04 @ 10:57 AM
Study NCT ID:
NCT04091451
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2019-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-03
First Submit QC Date:
None
Study First Post Date:
2019-09-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-15
Results First Submit QC Date:
None
Results First Post Date:
2025-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-27
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED